1,2,5,6-dibenzanthracene (dibenz(a,h)anthracene)

RN given refers to parent cpd
Also Known As:
dibenz(a,h)anthracene; 1,2,5,6-dibenzanthracene, ion(1+); 1,2,5,6-dibenzanthracene, ion(1-); dibenzo(a,h)anthracene
Networked: 31 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results


1. Glisic, Branka: 1 article (01/2015)
2. Barbosa, Fernando: 1 article (01/2015)
3. Campiglia, Andres D: 1 article (01/2015)
4. Brack, Werner: 1 article (01/2015)
5. Kovacevic, Radmila: 1 article (01/2015)
6. Dakic, Vanja: 1 article (01/2015)
7. Pogrmic-Majkic, Kristina: 1 article (01/2015)
8. Teodorovic, Ivana: 1 article (01/2015)
9. Goicoechea, Hector C: 1 article (01/2015)
10. Hrubik, Jelena: 1 article (01/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Hepatocellular Carcinoma (Hepatoma)
06/27/2003 - "Similar increases in E(2) hydroxylation, EROD activity, and CYP protein levels were observed with HepG2 human hepatoma and MCF-7 human breast cancer cells treated with FMEP or 1 microM dibenz[a,h]anthracene. "
04/01/1996 - "The metabolic activation of the potent carcinogen dibenzo[a,h]anthracene (DB[a,h]A) was investigated with recombinant human cytochrome P450 enzymes 1A2, 2B6, 2C8, 2C9, 2E1, 3A3, 3A4, and 3A5 expressed in hepatoma G2 cells and with 14 different human liver microsomes. "
01/01/2015 - "Rat hepatoma cells H4IIE were treated by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and polycyclic aromatic hydrocarbons (PAHs) (dibenz(a,h)anthracene, benzo(a)pyrene, benz(a)anthracene, chrysene), low-concentration mixtures of PAHs and TCDD, and environmental mixtures contaminated by PAHs and their derivatives. "
01/01/1982 - "differences in the rate of cellular uptake and formation of alkali-extractable metabolites of dibenzo[a,h]anthracene, 3-methylcholanthrene, and benzo[a]anthracene in Hepa-1 mouse hepatoma cell cultures do not account for differences in the capacity of these three polycyclic hydrocarbons to displace [3H]TCDD from the Ah receptor."
07/07/2012 - "To evaluate the change in gene expression levels, human hepatocellular carcinoma (HepG2) cells were exposed to nine different PAHs (benzo[a]pyrene, dibenzo[a,h]anthracene, 3-methylcholanthrene, naphthalene, chrysene, phenanthrene, benzo[a]anthracene, benzo[k]fluoranthene, and indeno[1,2,3-c,d]pyrene) for 48 h. "
4. Pulmonary Adenomatosis
5. Stupor

Related Drugs and Biologics

1. anthracene
2. Cytochrome P-450 CYP1A1 (CYP1A1)
3. 5-methylchrysene
4. Cytochrome P-450 CYP1A2 (CYP1A2)
5. Smoke
6. alyssin
7. sulforafan (sulforaphane)
8. Benzo(a)pyrene
9. benz(a)anthracene (benzanthracene)
10. pyrene

Related Therapies and Procedures

1. Oral Administration
2. Intravenous Injections